Haiyan Jiang
Janssen BioTherapeutics, USA
Biography
Haiyan has over 19 years of industry experience in the pharmaceutical and diagnostics areas. Haiyan joined Centocor R&D in 2004, which was later named Janssen BioTherapeutics. In the past 13 years at Janssen Haiyan leads a protein biochemistry group, focusing on developing and optimizing biotherapeutic lead molecules. She leads the group to work on purification and characterization of monoclonal antibodies, alternative scaffolds including bispecific antibodies, target antigens, receptors and other proteins for various research projects; developing new technologies to improve HTP purification and biochemical QC analyses; aligning with the methods from Discovery to Development process to ensure the smooth transfer of the therapeutic candidates from Lead optimization to Development stages. Haiyan received her Ph.D. in Microbiology at the University of Iowa. She then took a postdoctoral position at Eli Lilly and Company (Indianapolis). From 2000 to 2004, Haiyan worked at Roche Diagnostics Division (New Jersey) to lead a group responsible for developing purification process and manufacturing of recombinant DNA polymerases which were used for disease diagnosis.